Characteristics | All KF | KF from atheroembolic disease | KF all other causes | P-value |
---|---|---|---|---|
N= | 65,266 | 334 | 64,932 | |
Age at cohort entry (years) | 59 (49–71) | 72 (68–76) | 61 (49–71) | < 0.001 |
Male sex | 39,235 (60%) | 270 (81%) | 38,965 (60%) | < 0.001 |
Primary kidney disease | < 0.001 | |||
Atheroembolic | 334 (100%) | |||
Diabetic nephropathy | 21,811 (33%) | |||
Glomerulonephritis | 15,879 (24%) | |||
Reflux nephropathy | 1890 (3%) | |||
Polycystic disease | 3944 (6%) | |||
Hypertension | 8339 (13%) | |||
Other | 8866 (14%) | |||
Uncertain | 3716 (6%) | |||
Not reported | 487 (1%) | |||
Ethnicity | < 0.001 | |||
Caucasian | 45,720 (70%) | 321 (96%) | 45,399 (70%) | |
All Other | 19,544 (30%) | 13 (4%) | 19,531 (30%) | |
BMI (kg/m2)a | < 0.001 | |||
< 18.5 | 2165 (3%) | 16 (5%) | 2149 (3%) | |
18.5–24.9 | 22,195 (35%) | 174 (54%) | 22,021 (35%) | |
25–29.9 | 19,875 (32%) | 102 (31%) | 19,773 (32%) | |
≥ 30 | 18,702 (30%) | 33 (10%) | 18,669 (30%) | |
Comorbiditiesb | ||||
Diabetes mellitus | 28,147 (44%) | 76 (23%) | 36,141 (56%) | < 0.001 |
CAD | 19,920 (31%) | 265 (80%) | 19,920 (31%) | < 0.001 |
PVD | 11,653 (18%) | 195 (59%) | 11,458 (18%) | < 0.001 |
Chronic lung disease | 7986 (12%) | 77 (23%) | 7909 (12%) | < 0.001 |
Cerebrovascular disease | 7030 (11%) | 104 (32%) | 6926 (11%) | < 0.001 |
Current smokingc | 8532 (13%) | 43 (13%) | 8489 (13%) | 0.85 |
Country at cohort entry | < 0.001 | |||
Australia | 53,697 (83%) | 318 (95%) | 53,649 (83%) | |
New Zealand | 11,299 (17%) | 16 (5%) | 11,283 (17%) | |
Late referrald | 13,127 (21%) | 154 (51%) | 12,973 (21%) | < 0.001 |
Kidney biopsye | 18,903 (29%) | 92 (28%) | 18,811 (29%) | 0.92 |
Dialysis Era | ||||
1990–1998 | 13,282 (20%) | 96 (29%) | 13,186 (20%) | < 0.001 |
1999–2007 | 21,521 (33%) | 174 (52%) | 21,347 (32%) | |
2008–2017 | 30,463 (47%) | 64 (19%) | 30,399 (46%) | |
First dialysis modality | < 0.001 | |||
Facility HD | 46,540 (71%) | 275 (82%) | 46,265 (71%) | |
PD | 18,441 (28%) | 59 (18%) | 18,382 (28%) | |
HHD | 285 (0.5%) | 0 | 285 (0.44%) |